Drug Maker Teva Pharmaceuticals Agrees

NJ 2026 Independent Pharmacies
OIG False Claims Kickbacks
Penalty
$450 million

Outcome

OIG enforcement action against Drug Maker Teva Pharmaceuticals Agrees for false claims, kickbacks. Penalty: $450 million.

Details

Drug Maker Teva Pharmaceuticals Agrees — OIG Enforcement (2026)

OIG took enforcement action against Drug Maker Teva Pharmaceuticals Agrees in NJ in 2026 involving false claims, kickbacks violations in the Independent Pharmacies sector.

Penalty: $450 million

Violation types: False Claims, Kickbacks
Entity type: Pharmacy
Penalty type: Settlement
Location: NJ

Source: Drug Maker Teva Pharmaceuticals Agrees To Pay $450M In False Claims Act Settlement To Resolve Kickback Allegations Relating To Copayments And Price Fixing

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation.

Source: Drug Maker Teva Pharmaceuticals Agrees To Pay $450M In False Claims Act Settlement To Resolve Kickback Allegations Relating To Copayments And Price Fixing

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works